Skip to main content
News > Blog > News > Open Therapeutics Forms Alliance with Kudelski Security

Open Therapeutics Forms Alliance with Kudelski Security

Cincinnati, OH — May 4th, 2020 — Open Therapeutics, an open science therapeutic collaboration platform company announces its technology development alliance with Kudelski Security, the cybersecurity division of the multi-billion USD company, the Kudelski Group (SIX: KUD.S).

Due to Kudelski Security’s partner ecosystem, which reflects their product security and privacy applications behind their expertise with cryptography, blockchain development and Internet-of-Things (IoT) systems, Open Therapeutics committed to co-develop its blockchain features with Kudelski.

Open Therapeutics will work closely with Kudelski Security’s Blockchain Security Center to continue the build of its blockchain-based applications.

Kudelski Security’s blockchain expertise is built on more than 30 years’ of experience in cryptographic design, as well as more recent work in public blockchain cryptocurrency coin design and implementation, point of sale technology development, detailed audits of application code, protocol creation, and cryptographic algorithms for major industry players in the cryptocurrency, digital communications and IoT markets.

Kudelski Security will assist Open Therapeutics with the design, build, and implementation of the blockchain-related capabilities and technologies for the Therapoid platform, namely cryptocurrency, grant management, lab equipment management, gig and career board postings, and intellectual property management.

The blockchain applications will be developed on the Kudelski Trust Platform, a secure Amazon Web Services (AWS) Software as a Service (SaaS) solution that provides a highly secure DevSecOps Pipeline and associated AWS and Kudelski Security-develop services to enable rapid, agile development.

An initial focus of the results shall be enabling researchers to solve the COVID19 problem.

About Kudelski Security
Kudelski Security is the premier advisor and cybersecurity innovator for today’s most security-conscious organizations. Our long-term approach to client partnerships enables us to continuously evaluate their security posture to recommend solutions that reduce business risk, maintain compliance and increase overall security effectiveness. With clients that include Fortune 500 enterprises and government organizations in Europe and across the United States, we address the most complex environments through an unparalleled set of solution capabilities including consulting, technology, managed security services and custom innovation. For more information, visit

About Open Therapeutics 
The Company freely provides the scientific community the Therapoid™ platform; an open science collaboration therapeutic ecosystem that puts the scientist at the center of research and provides cryptocurrency rewards for participating in therapeutic collaborative research. Therapoid freely provides IP, access to grants and lab equipment, communication tools, manuscript development tool, preprint server, career opportunities, and rewards AnthroTokens™ cryptocurrency tokens for collaboration.

Our Effort

Open Therapeutics is a major backer of open science and open access efforts.

Open Therapeutics freely provides to science, technology, engineering, and math (STEM) scientists, or another other seriously interested persons, intellectual properties (patents, etc.), grant funding, lab equipment, document development tools, and preprint server in a collaboration platform (Therapoid™).

When the researchers advance the intellectual properties, s/he gains ScienceCoins™; a blockchain-based cryptocurrency.